We have extensive expertise both in the ‘Western’ academic research world as well as disease-endemic countries (particularly Africa) and through our work became increasingly aware that new tools against disease-transmitting insects are urgently needed and that science on its own will not be able to deliver these.
Existing insect vector control measures are not practical or efficient enough in the tropical and resource-poor areas of developing countries and their efficacy is even more threatened by increasing levels of insecticide resistance. Spraying of chemicals and use of insecticide-treated bednets will soon no longer do the trick. In developed regions, including Europe and the USA, there are also more and more problems with insect-transmitted diseases due to globalisation and climate change. People are becoming increasingly aware of these problems and demand effective and more sustainable control alternatives.
The In2Care founders all felt the urge to have a more direct and bigger impact on insect-transmitted diseases than merely publishing their research findings in scientific journals. The current gap between scientific discoveries and the consumer market sounded like an excellent niche for an independent research company. We, therefore, created In2Care and now have the chance to combine our academic background with our creative, yet practical and market-driven mindset. By rapidly transforming the latest scientific discoveries into commercially viable prototypes, we can valorise science and achieve real innovations with real impact!
With Bart, Marit and Remco, all with a PhD in Medical Entomology, In2Care has a clear scientific background, expertise, network and access to the latest scientific information. This is perfectly complemented with the product development expertise, industrial network and serial entrepreneur experience of Anne. Together, we are convinced, we can bridge the gap between science and the field.
